These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 15256819)

  • 1. Lithium acetate therapy in a maintenance hemodialysis patient.
    Walcher J; Schoecklmann H; Renders L
    Kidney Blood Press Res; 2004; 27(3):200-2. PubMed ID: 15256819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aluminum hydroxide, calcium carbonate and calcium acetate in chronic intermittent hemodialysis patients.
    Janssen MJ; van der Kuy A; ter Wee PM; van Boven WP
    Clin Nephrol; 1996 Feb; 45(2):111-9. PubMed ID: 8846523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lithium treatment in maintenance dialysis. Review of the literature and report of a new case on hemodialysis.
    Grüner JF; Dennert J; Schäfer G
    Pharmacopsychiatry; 1991 Jan; 24(1):13-6. PubMed ID: 2011616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimizing lithium dosing in hemodialysis.
    Bjarnason NH; Munkner R; Kampmann JP; Tornoe CW; Ladefoged S; Dalhoff K
    Ther Drug Monit; 2006 Apr; 28(2):262-6. PubMed ID: 16628141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of acetate and bicarbonate on the tolerance for hemodialysis therapy in chronic kidney failure].
    Shostka GD; T'iagi S; Kulikova AI; Spiridonov VN; Kostkina MI; Vitenberg AG
    Urol Nefrol (Mosk); 1990; (6):39-44. PubMed ID: 2089765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical and analytical changes in hemodialysis without acetate].
    Coll E; Pérez-García R; Rodríguez-Benítez P; Ortega M; Martínez Miguel P; Jofré R; López-Gómez JM
    Nefrologia; 2007; 27(6):742-8. PubMed ID: 18336105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intradialytic changes of serum magnesium and their relation to hypotensive episodes in hemodialysis patients on different dialysates.
    Elsharkawy MM; Youssef AM; Zayoon MY
    Hemodial Int; 2006 Oct; 10 Suppl 2():S16-23. PubMed ID: 17022745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous iron sucrose in Chinese hemodialysis patients with renal anemia.
    Li H; Wang SX
    Blood Purif; 2008; 26(2):151-6. PubMed ID: 18212498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel slow-release formulation of lithium carbonate (Carbolithium Once-A-Day) vs. standard Carbolithium: a comparative pharmacokinetic study.
    Castrogiovanni P
    Clin Ter; 2002; 153(2):107-15. PubMed ID: 12078335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The influence of short-term magnesium carbonate treatment on calcium-phosphorus balance in dialysis patients].
    Zwiech R; Dryja P; Łacina D; Króliczak V; Chrul S; Kacprzyk F
    Wiad Lek; 2011; 64(1):9-14. PubMed ID: 21812357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Duloxetine for the treatment of major depressive disorder: safety and tolerability associated with dose escalation.
    Wohlreich MM; Mallinckrodt CH; Prakash A; Watkin JG; Carter WP
    Depress Anxiety; 2007; 24(1):41-52. PubMed ID: 16845641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
    Tsubakihara Y; Nishi S; Akiba T; Hirakata H; Iseki K; Kubota M; Kuriyama S; Komatsu Y; Suzuki M; Nakai S; Hattori M; Babazono T; Hiramatsu M; Yamamoto H; Bessho M; Akizawa T
    Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Acetate-free on-line PHF: how to improve hyperacetatemia and haemodynamic tolerance].
    Coll E; Pérez-García R; Martín de Francisco AL; Galcerán J; García-Osuna R; Martín-Malo A; Martínez-Castelao A; Sánchez B; Llopis R; Alvarez de Lara MA
    Nefrologia; 2009; 29(2):156-62. PubMed ID: 19396322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of polyneuropathy severity in chronic renal failure patients on continuous ambulatory peritoneal dialysis or on maintenance hemodialysis].
    Janda K; Stompór T; Gryz E; Szczudlik A; Drozdz M; Kraśniak A; Sułowicz W
    Przegl Lek; 2007; 64(6):423-30. PubMed ID: 18159852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bicarbonate hemodialysis in the therapy of chronic kidney failure].
    Riabov SI; Shostka GD; Spiridonov VN; Vasil'ev AN; Kozlov VV
    Ter Arkh; 1988; 60(5):76-80. PubMed ID: 3175934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does concomitant administration of sevelamer and calcium carbonate modify the control of phosphatemia?
    Ouellet G; Cardinal H; Mailhot M; Ste-Marie LG; Roy L
    Ther Apher Dial; 2010 Apr; 14(2):172-7. PubMed ID: 20438539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between intradialytic hypotension in patients undergoing routine hemodialysis and use of acetate compared in bicarbonate dialysate.
    Thaha M; Yogiantoro M; Soewanto ; Pranawa
    Acta Med Indones; 2005; 37(3):145-8. PubMed ID: 16138418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of vancomycin when administered during high flux hemodialysis.
    Foote EF; Dreitlein WB; Steward CA; Kapoian T; Walker JA; Sherman RA
    Clin Nephrol; 1998 Jul; 50(1):51-5. PubMed ID: 9710347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistin serum levels are increased but not correlated with insulin resistance in chronic hemodialysis patients.
    Filippidis G; Liakopoulos V; Mertens PR; Kiropoulos T; Stakias N; Verikouki C; Patsidis E; Koukoulis G; Stefanidis I
    Blood Purif; 2005; 23(6):421-8. PubMed ID: 16141714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.